-
Continue reading →: Nanoformulation for HIV: Effects on Gut Immunity and BehaviorThe University of Texas, Rio Grande Valley (UTRGV) master’s student Blessed Ofori successfully defended his thesis, “Effect of an Anti-HIV Polymer-Based Nanoformulation on Immune Mediating Cells within the Gut Associated Lymphoid Tissue and Its Behavioral Impacts,” on November 15, 2024. Blessed investigated the cutting-edge nexus of immunology, behavioral science, and…
-
Continue reading →: Advancing Precision Medicine: Healthcare Innovation ResearchUpal Roy Dr. Upal Roy, an Associate Professor of Health &Biomedical Sciences stands at the forefront ofadvancements in healthcare innovation. His academicjourney reflects a steadfast commitment to enhancingthe accessibility, efficacy, and individualization ofhealthcare, with a specific emphasis on precisionmedicine. The transformative impact of Dr. Upal Roy’s workreaches beyond HIV treatment,…
-
Continue reading →: UTRGV awarded grant for anti-HIV drug researchResearchers at The University of Texas Rio Grande Valley’s Department of Health and Biomedical Sciences are working to develop a next generation of anti-HIV drugs that are more effective and have fewer side effects To further support the study of human immunodeficiency virus 1 (HIV-1)—still one of the leading causes of death worldwide, predominantly…
-
Continue reading →: Nanodiamond based anti-HIV drug delivery targeted towards the brainHuman Immunodeficiency Virus (HIV-1) remains one of the leading causes of death worldwide principally from developing countries. The present combined Antiretroviral Therapy (cART) has significantly reduced disease mortality among patients. However, major limitations in this treatment are the complexity of dosing regimens, drug metabolism, and numerous side effects. Furthermore, most…
Dr. Roy's Lab 